Authors
Loading...
Analysis reveals immune differences in EBV+ and EBV- Burkitt lymphoma, suggesting new treatment avenues.
Siciliano et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: